News New publication on drug discovery from REMEDi4ALL researchers REMEDi4ALL researchers based at the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP) and Fraunhofer…tools@teamitresearch.com24 May 2024
Demonstrator projectsNews REMEDi4ALL stands with the Osteogenesis Imperfecta (OI) Community on Wishbone Day Every year on the 6th of May, the Osteogenesis Imperfecta (OI, also known as brittle…tools@teamitresearch.com22 April 2024
FundersiDR24News REMEDi4ALL Funders Network holds its first hybrid meeting in Barcelona On 7 March 2024, over 80 attendees representing (non-) governmental funders, philanthropic entities, and pharmaceutical…tools@teamitresearch.com18 April 2024
iDR24News #iDR24 brings together the global drug repurposing community to advance scientific discussions and boost multistakeholder collaboration Over 250 experts from around the globe gathered in Barcelona for the inaugural International Drug…tools@teamitresearch.com17 April 2024
iDR24Uncategorized 3 Paths deep dive into innovations in cancer, rare diseases and methodologies #iDR24 offered the opportunity to explore and engage with content across three paths: Cancer, Methodologies…tools@teamitresearch.com17 April 2024
News Announcing the Winner of the #iDR24 Poster Competition! The #iDR24 conference hosted a dynamic Poster Session, providing a vibrant platform to showcase cutting-edge…tools@teamitresearch.com17 April 2024
FundersNewsResources REMEDi4ALL launches first drug repurposing-specific funding database Looking for funding for drug repurposing projects can be difficult - many funders do not…tools@teamitresearch.com12 April 2024
Uncategorized French newspaper Le Figaro publishes El País iDR24 REMEDi4ALL article Nick Sireau was getting ready to change his newborn son's diaper when he discovered a…admin28 March 2024
NewsPatientsRare Diseases University College London publishes iDR24 conference report The UCL Translational Research Office led a UCL academic delegation to join the first international…admin27 March 2024
FundersNewsPatientsRare DiseasesResources Spanish newspaper El País attends iDR24 and publishes article on untapped potential of drug repurposing Exciting insights from #iDR24! Oriol Güell from El País explores the enormous potential of drug…admin11 March 2024
NewsPatients Alan Finglas Honoured with WORLDSymposium Patient Advocate Leader Award At the 20th Annual WORLD Symposium in San Diego this February, the global spotlight shone…Piret Baur21 February 2024
News Report Published on the Training Landscape for Drug Repurposing In March 2023, a Curriculum Setting Meeting took place to define what the REMEDi4ALL consortium…tools@teamitresearch.com18 January 2024
Resources NOW LIVE: the REMEDI4ALL Learning Resources database REMEDi4ALL has launched a learning resources database where you can find a whole host of…tools@teamitresearch.com10 January 2024
Demonstrator projectsNewsUncategorized REMEDi4ALL hosts first Multi-Stakeholder Meeting on Pancreatic Cancer Pancreatic cancer, a rare and hard to treat type of cancer, is one of four…tools@teamitresearch.com12 December 2023
Funders International Funders Network established A worldwide network of funders focusing on drug repurposing has been established under the leadership…tools@teamitresearch.com9 November 2023
News EATRIS and the REMEDi4ALL Consortium to Initiate New Study to Advance Potential Treatment for Ultra-Rare Disease Tazarotene, originally approved as a topical cream for psoriasis and acne, will be investigated as…admin13 October 2023
Resources REMEDi4ALL Concierge: Connecting with the drug repurposing community The primary objective of the REMEDi4ALL Concierge is to actively engage with the repurposing community,…Piret Baur28 September 2023
Uncategorized REMEDi4ALL General Assembly Meeting brings together over 100 participants to discuss roadmap ahead The second REMEDi4ALL General Assembly meeting took place in Amsterdam last June 26-27. Around 100 participants representing…tools@teamitresearch.com27 September 2023
Demonstrator projects First Patients Recruited in a Repurposing Clinical Trial Funded Through REMEDi4ALL Image: Alfredo Boudillon, Scientific Director of Institution Pascale Institute Pascale, a renowned comprehensive cancer centre…Piret Baur14 September 2023
Funders REMEDi4ALL’s first workshop for funders on Innovating drug repurposing Over 50 representatives from (non-) governmental funders, philanthropies and pharmaceutical companies from around the world…Piret Baur13 September 2023